Elliot S Barnathan Selected Research

reteplase

2/2010	Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
10/2009	1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.
5/2008	Facilitated PCI in patients with ST-elevation myocardial infarction.
2/2004	Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elliot S Barnathan Research Topics

Disease

11	Hemorrhage 10/2022 - 04/2004
8	Asthma (Bronchial Asthma) 01/2019 - 10/2006
7	Venous Thromboembolism 10/2022 - 09/2018
7	Myocardial Infarction 01/2020 - 05/2003
7	Inflammation (Inflammations) 01/2018 - 06/2004
7	Sarcoidosis (Schaumann Disease) 01/2016 - 10/2006
5	Pulmonary Sarcoidosis 01/2016 - 08/2009
5	Acute Coronary Syndrome 02/2009 - 05/2003
4	Infections 01/2020 - 05/2007
4	Chronic Obstructive Pulmonary Disease (COPD) 03/2016 - 05/2007
4	ST Elevation Myocardial Infarction 02/2010 - 05/2008
3	Neoplasms (Cancer) 01/2019 - 05/2007
3	Ischemia 02/2010 - 07/2003
3	Thrombocytopenia (Thrombopenia) 12/2004 - 05/2003
2	Embolism (Embolus) 10/2022 - 11/2021
2	Thromboembolism 11/2021 - 01/2020
2	Bronchiectasis 01/2021 - 01/2019
2	Stroke (Strokes) 01/2020 - 01/2008
2	Respiratory Hypersensitivity 01/2019 - 03/2016
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2010 - 01/2008
2	Heart Failure 02/2009 - 07/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	COVID-19 01/2021
1	Melanoma (Melanoma, Malignant) 01/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Renal Insufficiency (Renal Failure) 09/2018
1	Disease Progression 12/2015
1	Idiopathic Pulmonary Fibrosis 12/2015
1	Necrosis 11/2014
1	Granuloma 11/2014
1	Lung Neoplasms (Lung Cancer) 03/2013
1	Hypertension (High Blood Pressure) 02/2009
1	Ischemic Stroke 01/2008
1	Pneumonia (Pneumonitis) 05/2007
1	Lung Diseases (Lung Disease) 05/2007
1	Opportunistic Infections (Opportunistic Infection) 05/2007
1	Peripheral Arterial Occlusive Disease 1 02/2004

Drug/Important Bio-Agent (IBA)

9	Infliximab (Remicade)FDA Link 01/2016 - 10/2006
8	RivaroxabanIBA 10/2022 - 09/2018
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 10/2006
6	Abciximab (ReoPro)FDA Link 02/2010 - 02/2004
5	Enoxaparin (Lovenox)FDA LinkGeneric 10/2022 - 02/2010
4	Monoclonal AntibodiesIBA 06/2011 - 02/2004
4	Heparin (Liquaemin)FDA LinkGeneric 02/2010 - 05/2003
4	reteplase FDA Link 02/2010 - 02/2004
3	AnticoagulantsIBA 01/2021 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2011
3	Biomarkers (Surrogate Marker)IBA 09/2017 - 07/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 10/2006
3	AntibodiesIBA 12/2004 - 05/2003
2	fibrin fragment D (D-dimer)IBA 01/2020 - 09/2018
2	Toll-Like Receptor 3IBA 01/2019 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2019 - 01/2018
2	Interleukin-13IBA 09/2017 - 12/2016
2	InterleukinsIBA 11/2014 - 06/2012
2	Interleukin-23 (Interleukin 23)IBA 11/2014 - 06/2012
2	golimumab FDA Link 11/2014 - 04/2009
2	Platelet Factor 4IBA 06/2004 - 05/2003
1	Pharmaceutical PreparationsIBA 10/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	InterferonsIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Interferon Type IIBA 01/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2018
1	toreforantIBA 11/2018
1	Histamine H4 ReceptorsIBA 11/2018
1	CNTO3157IBA 01/2018
1	PeriostinIBA 09/2017
1	Interleukin-4 (Interleukin 4)IBA 12/2016
1	Bronchodilator Agents (Bronchodilators)IBA 03/2016
1	Methacholine Chloride (Methacholine)FDA Link 03/2016
1	SteroidsIBA 03/2016
1	carlumabIBA 12/2015
1	LigandsIBA 12/2015
1	Carbon MonoxideIBA 12/2015
1	CC ChemokinesIBA 12/2015
1	Ustekinumab (CNTO 1275)FDA Link 11/2014
1	CytokinesIBA 11/2014
1	Prednisone (Sone)FDA LinkGeneric 01/2014
1	Interleukin-12 (IL 12)IBA 06/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012
1	Epidermal Growth Factor (EGF)IBA 02/2012
1	CD40 Ligand (CD40L)IBA 02/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2012
1	Blood Proteins (Serum Proteins)IBA 06/2011
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2011
1	VitronectinIBA 02/2009
1	TroponinIBA 02/2009
1	Phosphotransferases (Kinase)IBA 08/2007
1	MB Form Creatine KinaseIBA 08/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2007
1	Thrombin FDA Link 02/2004

Therapy/Procedure

10	Therapeutics 01/2019 - 10/2006
2	Percutaneous Coronary Intervention 10/2009 - 05/2008
1	Subcutaneous Injections 04/2009
1	Emergency Treatment 01/2008
1	Intravenous Administration 01/2008